Physician profile
Nicole David
NPI 1609287747
$3,045.95
in general payments reported to CMS, 2019-2025
40 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $643 · 2020: $315 · 2021: $1,211 · 2022: $553 · 2023: $143 · 2024: $27.07 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $323.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $471.37 | 2019-2022 | |
| Biogen, INC. | $240.48 | 2019-2022 | |
| Emd Serono, INC. | $221.51 | 2019-2021 | |
| Ucb, INC. | $203.40 | 2019-2022 | |
| Abbvie INC. | $192.29 | 2021-2024 | Botox, Ubrelvy |
| Medtronic, INC. | $153.27 | 2025 | Linq II |
| Genzyme Corporation | $123.23 | 2019-2023 | |
| Alexion Pharmaceuticals, INC. | $113.27 | 2021-2022 | |
| Lilly USA, LLC | $107.49 | 2020-2022 | |
| Amgen INC. | $99.77 | 2021-2022 | |
| Allergan, INC. | $93.73 | 2019-2022 | |
| Mdd US Operations, LLC | $87.79 | 2019-2021 | |
| Adamas Pharmaceuticals, INC. | $84.59 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $61.64 | 2021 | |
| Alnylam Pharmaceuticals INC. | $60.05 | 2019-2020 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $59.52 | 2019-2021 | |
| Genentech USA, INC. | $58.46 | 2019-2020 | |
| Greenwich Biosciences, INC. | $56.49 | 2021 | |
| Acadia Pharmaceuticals INC | $48.92 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $47.66 | 2021-2022 | |
| Medline Industries LP | $41.60 | 2023 | |
| Philips North America LLC | $41.20 | 2022 | |
| Zyla Life Sciences, INC. | $36.34 | 2019-2020 | |
| Celgene Corporation | $34.41 | 2022 | |
| Sunovion Pharmaceuticals INC. | $33.06 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $29.76 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $25.91 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $22.36 | 2019 | |
| Akcea Therapeutics, INC. | $21.60 | 2019 | |
| Neurelis, INC. | $21.57 | 2022 | |
| Sk Life Science, INC. | $20.28 | 2022 | |
| Merz Pharmaceuticals, LLC | $19.00 | 2021 | |
| Horizon Therapeutics Plc | $17.80 | 2022 | |
| Ironshore Pharmaceuticals INC. | $17.24 | 2021 | |
| Neurocrine Biosciences, INC. | $15.88 | 2021 | |
| Bausch Health US, LLC | $13.78 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.41 | 2022 | |
| Zogenix INC. | $12.60 | 2021 | |
| Avanir Pharmaceuticals, INC. | $12.23 | 2020 | |
| Electromed, INC. | $10.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole David listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.